Advertisement

Topics

Roche unloads some rights to drug hopeful after asthma trial disappointment

13:24 EDT 8 Aug 2017 | Reuters

ZURICH (Reuters) - Roche is offloading some rights to what was once one of its top drug prospects, lebrikizumab, for payments which could total more than $1 billion after the medicine produced only lacklustre results in an asthma study last year.

Original Article: Roche unloads some rights to drug hopeful after asthma trial disappointment

NEXT ARTICLE

More From BioPortfolio on "Roche unloads some rights to drug hopeful after asthma trial disappointment"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...